title: Short-term depression and long-term enhancement of ACh-gated channel currents induced by linoleic and linolenic acid.
abstract: The effects of cis-unsaturated free fatty acids such as linoleic and linolenic acid on ACh-evoked currents were examined using normal and mutant nicotinic acetylcholine (ACh) receptors lacking protein kinase C (PKC) phosphorylation sites on the alpha and delta subunits expressed in Xenopus oocytes. These free fatty acids reduced ACh-gated channel currents during treatment and to a greater extent in Ca2+-free extracellular solution. After treatment, the currents were enhanced as the drug was washed out, but this effect was not observed in the absence of extracellular Ca2+. Linolenic acid was more potent of the current enhancement (300% of the control) than linoleic acid (190% of the control). The current enhancement induced by these free fatty acids was inhibited by the selective PKC inhibitor, GF109203X, while the current depression was not affected. Furthermore, these lipids decreased ACh-evoked currents in mutant ACh receptors to the same extent as in normal ACh receptors, but never enhanced the currents. These results indicate that linoleic and linolenic acid have biphasic actions on ACh receptor currents; a short-term depression and a long-term enhancement. The short-term depression may be due to an interaction with the ACh receptor channels, presumably at Ca2+ binding sites. The long-lasting enhancement appears to result from Ca2+-dependent PKC activation followed by PKC phosphorylation of the ACh receptors.
authors.affiliation: Department of Physiology, Kobe University School of Medicine, Chuo-ku, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Nishizaki
authors.forename: Y
authors.initials: Y
authors.lastname: Ikeuchi
authors.forename: T
authors.initials: T
authors.lastname: Matsuoka
authors.forename: K
authors.initials: K
authors.lastname: Sumikawa
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology*; D000818:Animals; D004553:Electric Conductivity; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D007211:Indoles / Q000494:pharmacology; D015640:Ion Channel Gating; D007473:Ion Channels / Q000037:antagonists & inhibitors / Q000187:drug effects* / Q000502:physiology*; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000494:pharmacology*; D008301:Maleimides / Q000494:pharmacology; D009154:Mutation; D018408:Patch-Clamp Techniques; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D011950:Receptors, Cholinergic / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D013997:Time Factors; D014101:Torpedo; D014981:Xenopus; D017962:alpha-Linolenic Acid / Q000494:pharmacology*
chemical_list: D004791:Enzyme Inhibitors; D007211:Indoles; D007473:Ion Channels; D008041:Linoleic Acids; D008301:Maleimides; D011950:Receptors, Cholinergic; D017962:alpha-Linolenic Acid; D019787:Linoleic Acid; D011493:Protein Kinase C; C070515:bisindolylmaleimide I; D000109:Acetylcholine